Entity Common Stock, Shares Outstanding of ENvue Medical, Inc. from 15 May 2015 to 19 Aug 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ENvue Medical, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 May 2015 to 19 Aug 2025.
  • ENvue Medical, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 19 Aug 2025 was 796,950, a 79% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ENvue Medical, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 796,950 -2,955,404 -79% 19 Aug 2025 10-Q 19 Aug 2025 2025 Q2
Q2 2025 2,584,835 -199,519 -7.2% 20 May 2025 10-Q 20 May 2025 2025 Q1
Q1 2025 759,297 -2,025,057 -73% 31 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 3,752,354 +1,706,046 +83% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 2,784,354 +1,122,024 +67% 14 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 2,784,354 +1,121,977 +67% 08 Apr 2024 10-K/A 09 Apr 2024 2023 FY
Q3 2023 2,046,308 -25,951,485 -93% 13 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 1,662,330 -26,335,463 -94% 11 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 1,662,377 -26,335,416 -94% 17 Apr 2023 10-K 17 Apr 2023 2022 FY
Q3 2022 27,997,793 +3,888,159 +16% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 27,997,793 11 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 27,997,793 +3,888,158 +16% 14 Apr 2022 10-K 15 Apr 2022 2021 FY
Q4 2021 27,946,793 +14,553,140 +109% 15 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q3 2021 24,109,634 +19,120,870 +383% 16 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 24,109,635 23 Mar 2021 10-K 15 Apr 2021 2020 FY
Q4 2020 13,393,653 +8,939,889 +201% 15 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q3 2020 4,988,764 18 Aug 2020 10-Q/A 24 Aug 2020 2020 Q2
Q2 2020 4,313,764 -116,200 -2.6% 03 Jul 2020 10-Q 06 Jul 2020 2020 Q1
Q4 2019 4,453,764 15 Nov 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 4,429,964 +472,011 +12% 13 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 4,076,552 +140,687 +3.6% 15 Apr 2019 10-K 13 May 2019 2018 FY
Q3 2018 4,003,535 +228,779 +6.1% 14 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 3,957,953 +1,325,243 +50% 14 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 3,935,865 +1,303,155 +49% 01 Apr 2018 10-K 29 Mar 2018 2017 FY
Q3 2017 3,774,756 +1,142,046 +43% 14 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 2,632,710 +9,000 +0.34% 14 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 2,632,710 +9,000 +0.34% 31 Mar 2017 10-K/A 26 Jul 2017 2016 FY
Q3 2016 2,632,710 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 2,623,710 +12,382 +0.47% 16 May 2016 10-Q 16 May 2016 2016 Q1
Q1 2016 2,623,710 +12,382 +0.47% 30 Mar 2016 10-K 30 Mar 2016 2015 FY
Q4 2015 2,611,328 16 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 2,611,328 14 Aug 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 2,611,328 15 May 2015 10-Q 10 Jun 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.